Showing results (601-610 of 16,153) with videos related to
Sort By:
Pageof 1,616
European Journal of Medicinal Chemistry|July 10, 2023
Discovery of tetrahydroisoquinolineindole derivatives as first dual PRMT5 inhibitors/hnRNP E1 upregulators: Design, synthesis and biological evaluationWen-Hui Chu, Na Yang, Jin-He Zhang, et al.European Journal of Medicinal Chemistry|July 9, 2023
Recent advances in Fragment-based strategies against tuberculosisBaptiste Villemagne, Léo Faion, Salia Tangara, et al.European Journal of Medicinal Chemistry|July 5, 2023
Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLCBin Liu, Feng Gao, Hui Zhao, et al.European Journal of Medicinal Chemistry|June 28, 2023
Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probesJuliette Delahaye, Miriam Stölting, Christiane Geyer, et al.European Journal of Medicinal Chemistry|July 29, 2023
Conjugation of antimicrobial peptides to enhance therapeutic efficacySanjay Prasad Selvaraj, Jyh-Yih ChenEuropean Journal of Medicinal Chemistry|June 22, 2023
Membrane-active substituted triazines as antibacterial agents against Staphylococcus aureus with potential for low drug resistance and broad activitySaurabh Gupta, Kamaldeep PaulEuropean Journal of Medicinal Chemistry|April 2, 2003
Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailabilityYasufumi Kawanaka, Kaoru Kobayashi, Shinya Kusuda, et al.European Journal of Medicinal Chemistry|April 2, 2003
Synthesis and evaluation of 2-tosylamino and 2-tosyliminopyrimidine derivatives as inhibitors of some leukocyte functionsPatricia Fernandez-Ferri, Amalia Ubeda, Isabel Guillén, et al.European Journal of Medicinal Chemistry|April 2, 2003
Constitutional isomers of Reactive Blue 2 - selective P2Y-receptor antagonists?Markus Glänzel, Ralph Bültmann, Klaus Starke, et al.European Journal of Medicinal Chemistry|March 28, 2003
1,5-benzodiazepines. Part XIII. Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo[1,2-a][1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicityGiancarlo Grossi, Mario Di Braccio, Giorgio Roma, et al.Pageof 1,616